Gilead Announces Latest Data in Ongoing HIV Cure Research Program

Go back to Gilead Announces Latest Data in Ongoing HIV Cure Research Program
Gilead Sciences (NASDAQ: GILD) Delayed: 152.67 +2.11 (1.40%)
Previous Close $150.56    52 Week High $108.63 
Open $150.65    52 Week Low $71.39 
Day High $153.28    P/E 84.35 
Day Low $148.65    EPS $1.81 
Volume 4,948,287